CSS
HALO icon

Cubist Systematic Strategies’s Halozyme HALO Stock Holding History

Cubist Systematic Strategies’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-44,300
Closed -$1.69M – 3783
2023
Q3 		$1.69M Sell
44,300
-400
-0.9% -$16.4K 0.01% 1486
2023
Q2 		$1.61M Buy
+44,700
New +$1.53M 0.01% 1645

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Cubist Systematic Strategies's HALO Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Halozyme (HALO) in Q2 2024, closing a stake of 319,296 shares — an estimated $13M sold.

Cubist Systematic Strategies first reported a position in HALO in Q4 2014 and held it in 32 quarters. The position peaked at $13M in Q1 2024. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 319,296 Halozyme shares in Q2 2024, an estimated $13M.
  • Cubist Systematic Strategies first reported a position in Halozyme in Q4 2014 and held it in 32 quarters.
  • Cubist Systematic Strategies's Halozyme position peaked at $13M in Q1 2024.
  • 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.